You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
眾生藥業(002317.SZ)跳漲3% ZSP1273片臨牀研究取得實質性進展
格隆匯 12-09 09:40
格隆匯12月9日丨眾生藥業(002317.SZ)跳空高開後進一步拉昇,目前漲幅擴大至3%,報10.24元,暫成交2643萬元,最新總市值83.4億元。眾生藥業昨晚公告,控股子公司眾生睿創組織開展的用於預防和治療甲型流感及人禽流感的一類創新藥物ZSP1273片的臨牀試驗,已在全國二十五家臨牀研究中心開展Ⅱ期臨牀試驗,目前首例受試者已入組。ZSP1273片Ⅱ期臨牀試驗的首例受試者入組,標誌着ZSP1273片臨牀研究進一步取得了實質性進展,併為其成功上市邁出了堅實的一步。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account